top of page
CapsuLINT is an Israeli based pharma company that has developed an Oral drug delivery system, designed for facilitated dissolution and potential increased permeability and oral absorption of low solubility drugs and/or low permeability type drugs, in a nano size amorphous dispersion.
- US Patent granted - Patent No. US 8,187,615 (Application No. 10/585,298) Title: "Non-Aqueous Composition for Oral Delivery of Insoluble Bioactive Agents”
- Docetaxel Clinical Proof of principle PK in rats
Allan Aginsky - Co Founder CapsuLINT
Doron Freidman - Co Founder & CTO CapsuLINT
Alon Blankstein - Co Founder CapsuLINT
bottom of page